Abstract
Onconase is an RNase of the ribonuclease A superfamily that is purified from the Northern leopard frog (Rana pipiens). It targets several types of malignant tumors, digests cytoplasmic transfer RNA (tRNA), and causes tumor cell apoptosis. Onconase has been employed in clinical trials as an antitumor drug, and has revealed its valuable clinical activity in several types of tumors, particularly pleural mesothelioma. However, its inefficiency in targeting tumor cells and its non‑specific toxicity in normal tissues have diminished its clinical benefits. Furthermore, cyclization of the N-terminal glutamine residue (Gln), possesses more RNase activity than the structure of Met ahead of Glu in the N-terminal (99:1), which is more difficult for producing onconase by Pichia pastoris. Under the guidance of α-mating factor-pre (α-MF-pre) secretion signal, the secretion of the recombinant protein can reach a high level. In the present study, we constructed a constitutive expression vector for onconase-(DV3)2 (Onc-DV3) production in yeast Pichia pastoris with the GAP promoter, in which the Onc-DV3 gene is inserted downstream of the truncated Saccharomyces cerevisiae α-mating factor-pre (α-MF-pre) secretion signal. The immuno-RNase Onc-DV3 e...Continue Reading
References
Mar 4, 1994·Journal of Molecular Biology·S C MosimannM N James
Jul 21, 1999·Cancer Chemotherapy and Pharmacology·V M VasandaniC Sung
Apr 1, 2000·The Journal of Biological Chemistry·L E BretscherR T Raines
Jan 12, 2001·Blood·D L NewtonS M Rybak
May 30, 2001·Journal of Biotechnology·A VassilevaN Khanna
Feb 13, 2002·The Journal of Biological Chemistry·Shailendra K SaxenaRichard J Youle
Oct 7, 2003·Oncogene·Sylvie MénardElda Tagliabue
Dec 3, 2003·The Journal of Biological Chemistry·Vitaliy Y GorbatyukTai-huang Huang
Apr 9, 2004·Pharmaceutical Research·Eric L Snyder, Steven F Dowdy
Jul 13, 2004·Seminars in Cancer Biology·Fran Balkwill
Dec 8, 2004·Biotechnology and Bioengineering·Jayanta SinhaMichael M Meagher
Feb 11, 2005·Yeast·Sue Macauley-PatrickLinda M Harvey
Aug 23, 2005·EMBO Reports·Qian WangZhixiang Wang
Sep 3, 2005·Analytical Biochemistry·Külliki SaarUlo Langel
Nov 8, 2005·The Journal of Biological Chemistry·Melanie Rhee, Pamela Davis
Dec 3, 2005·Cancer Research·Eric L SnyderSteven F Dowdy
Feb 25, 2006·The Journal of Biological Chemistry·Avvaru N Suhasini, Ravi Sirdeshmukh
Mar 22, 2006·Expert Opinion on Biological Therapy·Nick Pavlakis, Nicholas J Vogelzang
Apr 20, 2006·Analytical Biochemistry·Sangwei LuLee W Riley
Nov 4, 2006·The Journal of Biological Chemistry·Marianela Perez-TorresCarlos L Arteaga
Mar 22, 2007·Journal of Cell Science·Montserrat RodríguezBruno Beaumelle
May 5, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Catherine L WatkinsArwyn T Jones
Jan 14, 2010·Cancer Research·Mikkel Wandahl PedersenMichael Kragh
Jul 29, 2010·Molecular Cancer Therapeutics·Chien-Hsing ChangDavid M Goldenberg
Nov 3, 2011·Organic & Biomolecular Chemistry·Jung Woo ParkByeang Hyean Kim
Nov 8, 2011·Applied Microbiology and Biotechnology·Leonardo M DamascenoCarl A Batt
Jan 17, 2012·Applied Biochemistry and Biotechnology·Xiaofeng WangYunjun Yan